Ryan D Nipp1, Carolyn L Qian2, Helen P Knight3, Cristina R Ferrone4, Hiroko Kunitake4, Carlos Fernandez-Del Castillo4, Michael Lanuti4, Motaz Qadan4, Rocco Ricciardi4, Keith D Lillemoe4, Brandon Temel2, Ardeshir Z Hashmi5, Erin Scott6, Erin Stevens6, Grant R Williams7, Zhi Ven Fong4, Terrence A O'Malley8, Esteban Franco-Garcia8, Nora K Horick9, Vicki A Jackson8, Joseph A Greer10, Areej El-Jawahri2, Jennifer S Temel2. 1. Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA. Electronic address: rnipp@mgh.harvard.edu. 2. Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA. 3. Department of Medicine, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA. 4. Department of Surgery, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA. 5. Department of Internal Medicine and Geriatrics, Cleveland Clinic, Cleveland, OH, USA. 6. Department of Internal Medicine, Division of Palliative Medicine, Ohio State University, Columbus, OH, USA. 7. Department of Medicine, Division of Hematology & Oncology, The University of Alabama at Birmingham, Birmingham, AL, USA. 8. Department of Medicine, Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA. 9. Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA. 10. Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: Older adults with gastrointestinal cancers undergoing surgery often experience poor outcomes, such as prolonged postoperative hospital length of stay (LOS), intensive care unit (ICU) use, hospital readmissions, and complications. Involvement of geriatricians in the care of older adults with cancer can improve outcomes. We conducted a randomized trial of a perioperative geriatric intervention (PERI-OP) in older patients with gastrointestinal cancer undergoing surgery. METHODS: From 9/2016-4/2019, we randomly assigned patients age ≥ 65 with gastrointestinal cancer planning to undergo surgical resection to receive PERI-OP or usual care. Patients assigned to PERI-OP met with a geriatrician preoperatively in the outpatient setting and postoperatively as an inpatient consultant. The primary outcome was postoperative hospital LOS. Secondary outcomes included postoperative ICU use, 90-day hospital readmission rates, and complication rates. We conducted intention-to-treat (ITT) and per-protocol (PP) analyses. RESULTS: ITT analyses included 137/160 patients who underwent surgery (usual care = 68/78, intervention = 69/82). PP analyses included the 68 usual care patients and the 30/69 intervention patients who received the preoperative and postoperative intervention components. ITT analyses demonstrated no significant differences between intervention and usual care in postoperative hospital LOS (7.23 vs 8.21 days, P = 0.374), ICU use (23.2% vs 32.4%, P = 0.257), 90-day hospital readmission rates (21.7% vs 25.0%, P = 0.690), or complication rates (17.4% vs 20.6%, P = 0.668). In PP analyses, intervention patients had shorter postoperative hospital LOS (5.90 vs 8.21 days, P = 0.024), but differences in ICU use (13.3% vs 32.4%, P = 0.081), 90-day hospital readmission rates (16.7% vs 25.0%, P = 0.439), and complication rates (6.7% vs 20.6%, P = 0.137) remained non-significant. CONCLUSIONS: In this randomized trial, PERI-OP did not have a significant impact on postoperative hospital LOS, ICU use, hospital readmissions, or complications. However, the subgroup who received PERI-OP as planned experienced encouraging results. Future studies of PERI-OP should include efforts, such as telehealth, to ensure the intervention is delivered as planned.
BACKGROUND: Older adults with gastrointestinal cancers undergoing surgery often experience poor outcomes, such as prolonged postoperative hospital length of stay (LOS), intensive care unit (ICU) use, hospital readmissions, and complications. Involvement of geriatricians in the care of older adults with cancer can improve outcomes. We conducted a randomized trial of a perioperative geriatric intervention (PERI-OP) in older patients with gastrointestinal cancer undergoing surgery. METHODS: From 9/2016-4/2019, we randomly assigned patients age ≥ 65 with gastrointestinal cancer planning to undergo surgical resection to receive PERI-OP or usual care. Patients assigned to PERI-OP met with a geriatrician preoperatively in the outpatient setting and postoperatively as an inpatient consultant. The primary outcome was postoperative hospital LOS. Secondary outcomes included postoperative ICU use, 90-day hospital readmission rates, and complication rates. We conducted intention-to-treat (ITT) and per-protocol (PP) analyses. RESULTS: ITT analyses included 137/160 patients who underwent surgery (usual care = 68/78, intervention = 69/82). PP analyses included the 68 usual care patients and the 30/69 intervention patients who received the preoperative and postoperative intervention components. ITT analyses demonstrated no significant differences between intervention and usual care in postoperative hospital LOS (7.23 vs 8.21 days, P = 0.374), ICU use (23.2% vs 32.4%, P = 0.257), 90-day hospital readmission rates (21.7% vs 25.0%, P = 0.690), or complication rates (17.4% vs 20.6%, P = 0.668). In PP analyses, intervention patients had shorter postoperative hospital LOS (5.90 vs 8.21 days, P = 0.024), but differences in ICU use (13.3% vs 32.4%, P = 0.081), 90-day hospital readmission rates (16.7% vs 25.0%, P = 0.439), and complication rates (6.7% vs 20.6%, P = 0.137) remained non-significant. CONCLUSIONS: In this randomized trial, PERI-OP did not have a significant impact on postoperative hospital LOS, ICU use, hospital readmissions, or complications. However, the subgroup who received PERI-OP as planned experienced encouraging results. Future studies of PERI-OP should include efforts, such as telehealth, to ensure the intervention is delivered as planned.
Authors: Andrew S Barbas; Ryan S Turley; Eugene P Ceppa; Srinevas K Reddy; Dan G Blazer; Bryan M Clary; Theodore N Pappas; Douglas S Tyler; Rebekah R White; Sandhya A Lagoo Journal: J Am Geriatr Soc Date: 2011-12-28 Impact factor: 5.562
Authors: Jeanne M Huddleston; Kirsten Hall Long; James M Naessens; David Vanness; Dirk Larson; Robert Trousdale; Matt Plevak; Miguel Cabanela; Duane Ilstrup; Robert M Wachter Journal: Ann Intern Med Date: 2004-07-06 Impact factor: 25.391
Authors: Hans Wildiers; Pieter Heeren; Martine Puts; Eva Topinkova; Maryska L G Janssen-Heijnen; Martine Extermann; Claire Falandry; Andrew Artz; Etienne Brain; Giuseppe Colloca; Johan Flamaing; Theodora Karnakis; Cindy Kenis; Riccardo A Audisio; Supriya Mohile; Lazzaro Repetto; Barbara Van Leeuwen; Koen Milisen; Arti Hurria Journal: J Clin Oncol Date: 2014-08-20 Impact factor: 44.544
Authors: Tyler R Chesney; Barbara Haas; Natalie G Coburn; Alyson L Mahar; Victoria Zuk; Haoyu Zhao; Frances C Wright; Amy T Hsu; Julie Hallet Journal: JAMA Surg Date: 2020-11-18 Impact factor: 14.766
Authors: Darryl Outlaw; Maya Abdallah; Luiz A Gil-Jr; Smith Giri; Tina Hsu; Jessica L Krok-Schoen; Gabor Liposits; Tânia Madureira; Joana Marinho; Ishwaria M Subbiah; Gina Tuch; Grant R Williams Journal: Semin Radiat Oncol Date: 2022-04 Impact factor: 5.934
Authors: Jennifer L Lund; Paul R Duberstein; Kah Poh Loh; Nikesha Gilmore; Sandy Plumb; Lianlian Lei; Alexander P Keil; Jessica Y Islam; Laura C Hanson; Jeffrey K Giguere; Victor G Vogel; Brian L Burnette; Supriya G Mohile Journal: J Geriatr Oncol Date: 2021-09-02 Impact factor: 3.599
Authors: Clark DuMontier; Hajime Uno; Tammy Hshieh; Guohai Zhou; Richard Chen; Emily S Magnavita; Lee Mozessohn; Houman Javedan; Richard M Stone; Robert J Soiffer; Jane A Driver; Gregory A Abel Journal: Haematologica Date: 2022-05-01 Impact factor: 11.047
Authors: Christopher E Jensen; Sanah N Vohra; Kirsten A Nyrop; Allison M Deal; Hyman B Muss; Eben I Lichtman; Samuel M Rubinstein; William A Wood; Nicholas J Mangieri; Lee Jamison; Shakira J Grant; Sascha A Tuchman Journal: J Geriatr Oncol Date: 2021-08-11 Impact factor: 3.929